Skip to content

MEDSABOR

Active Private limited company (pre-2019)founded 1999active for 27 yearsRue du Tombois 9, 6500 BeaumontKBO/BCE: BE 0465.584.063

Lifetime

20 annual accounts with figures on one time axis, 27 filings since 1999
peak of €120,650 in 2006
€22,089▲ 84.8%
lowest -€19,124 in 2018
€28,998▲ 222%
peak of €554,747 in 2017
€173,103▼ 48.3%
€10,222▲ 21×
peak of 0.9 FTE in 2006
-not published
Board1 name since 2013
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €11,956 to €22,089Result from €9,003 to €28,998Dividend €191,000Equity from €335,104 to €173,103Debts from €484 to €10,222Cash from €32,522 to €6,363

Key points

from the 2025 annual accounts

Equity

€173,103 ▼ 48.3%
335,1042024+28,998Profit-191,000Dividend173,1032025

MEDSABOR paid out €191,000 in dividends. That is 659% of the 2025 profit.

Turnover

≈ €160,000 estimated

The accounts state no turnover.

Filings

27 annual accounts since 1999
AprilJune31 JulyOctober200020102020

Six of the last ten came late. The 2025 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as MEDSABOR has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for MEDSABOR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • all the sharesdeed of 11-05-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0465584063
Capital decrease to €18,592 The capital fell from €255,592 to €18,592, cancelling 1,553 shares · holds all the shares · General meeting of 14-03-2018 · Gazette deed
Capital increase of €236,700 holds 2,303 shares · General meeting of 31-12-2013 · Gazette deed
reappointed as manager General meeting of 11-08-2011 · Gazette deed
All 43 events

Official details

Source: KBO
Status
Active since 08-03-1999Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unit
Joint committee
330Health institutions and services · annual accounts 2021
Establishment unit
2.230.479.5646500 Beaumont, since 22-02-1999
Financial year end
31 December
Peppol
Reachable since 11-10-2026
Company details

Annual accounts 2025

€183,324▼ 45.4%
Filing
Filed on 31-08-2026
Financials

Insights on MEDSABOR

MEDSABOR files the micro format. That format states no turnover. The gross margin fell from €120,650 in 2006 to €22,089 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDSABOR

What is the company number of MEDSABOR?
The company number of MEDSABOR is 0465.584.063. The VAT number is the same number with BE in front: BE 0465.584.063.
Where is MEDSABOR based?
The registered office is at Rue du Tombois 9, 6500 Beaumont.Company details
What is the legal form of MEDSABOR?
MEDSABOR is a private limited company (pre-2019) (BVBA).
When was MEDSABOR founded?
MEDSABOR was founded on 08-03-1999.
Is MEDSABOR still active?
Yes, MEDSABOR is an active enterprise in the KBO register.
How many employees does MEDSABOR have?
MEDSABOR had an average of 0.7 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does MEDSABOR fall under?
In its 2021 annual accounts, MEDSABOR states joint committee 330 (Health institutions and services).
What is the turnover of MEDSABOR?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €22,089 and 7,098 comparable companies of the same size. It probably lies between €75,000 and €390,000. It is a rough estimate.
Is MEDSABOR profitable?
In financial year 2025, MEDSABOR made a profit of €28,998.
Where can I find the annual accounts of MEDSABOR?
MEDSABOR filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDSABOR due?
MEDSABOR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.